Table 2.
Association between baseline clinical and laboratory characteristics and nephrology consultation of AKI patients lately referred to nephrologist in developing country (n = 103)
| Characteristics | Nephrology consultation | p | |
|---|---|---|---|
| ≤ 4 days (n = 56) | > 4 days (n = 47) | ||
| Male | 38 (67.85) | 40 (85.11) | 0.980 |
| Age ≥ 60 years | 37 (66.07) | 26 (55.32) | 0.265 |
| Oliguria | 38 (67.85) | 35 (74.47) | 0.462 |
| Serum creatinine (mg/dL) | |||
| Baseline | 3.1 (2.47) | 4.1 (4.11) | 0.198 |
| Maximum | 4.5 (2.92) | 4.6 (3.38) | 0.292 |
| Blood urea nitrogen (mg/dL) | |||
| Baseline | 66.57 (31.58) | 70.17 (38.99) | 0.606 |
| Maximum | 94 (37.96) | 93.63 (31.3) | 0.959 |
| Serum potassium (mg/dL) | |||
| Baseline | 4.61 (1.07) | 4.69 (1.43) | 0.758 |
| Maximum | 5.14 (1.22) | 5.05 (1.01) | 0.675 |
| AKIN | |||
| stage I | 21 (38.88) | 14 (29.78) | 0.437 |
| stage II | 4 (7.41) | 2 (4.25) | |
| stage III | 29 (53.7) | 31 (65.95) | |
| KDIGO | |||
| stage I | 21 (38.88) | 14 (29.78) | 0.437 |
| stage II | 4 (7.41) | 2 (4.25) | |
| stage III | 29 (53.7) | 31 (65.95) | |
| Hemodialysis | 38 (67.85) | 47 (68.11) | 0.128 |
| Mortality | 28 (50.0) | 35 (74.46) | 0.011 |
Results are expressed in number (%), mean ± SD or median (25–75 IQR). AKIN: Acute Kidney Injury Network. KDIGO: Kidney Disease: Improving Global Outcomes